Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review

BACKGROUND: Guidelines recommend that treatment with a long-acting β(2) agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symptomatic patients with chronic obstructive pulmonary disease (COPD) who con...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Res
Hlavní autoři: Langham, Sue, Lewis, Jen, Pooley, Nick, Embleton, Nina, Langham, Julia, Han, MeiLan K., Chalmers, James D.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829989/
https://ncbi.nlm.nih.gov/pubmed/31684965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1213-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky